[Microangiopathic hemolytic anemia in metastatic carcinoma (author's transl)].
D000743:Anemia, Hemolytic / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D001778:Blood Coagulation Disorders / Q000150:complications; D001803:Blood Transfusion; D003937:Diagnosis, Differential; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D004913:Erythrocytes, Abnormal; D006242:Haptoglobins; D006461:Hemolysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000150:complications*; D011379:Prognosis; D013927:Thrombosis
D006242:Haptoglobins; D006493:Heparin
Mikroangiopathische hämolytische Anämie bei malignen Tumorekrankungen